Abstract
High-density lipoprotein (HDL) has been shown to have a variety of functions that contribute to anti-atherogenesis. Therefore, low HDL-cholesterol (HDL-C) level is significantly associated with the development of coronary artery diseases (CADs). Soy and isoflavones have been proposed to reduce the risk of CAD. However, the underlying mechanisms for soy and isoflavone-induced reduction of coronary risks remain largely unknown. To understand effects of lifestyle on lipids metabolism, the existence of interracial differences should be considered. Here we reviewed published articles about effects of soy and isoflavone intake on HDL metabolism. We regarded systematic review and meta-analysis and also clinical studies which were performed in Asian populations as important articles in this review. Evidences obtained from clinical trials performed in Asian populations showed that effects of soy protein and isoflavones on HDL-C were limited, which may be due to limited studied population such as postmenopausal women. Meta-analyses indicated that intake of soy protein and isoflavones is beneficially associated with HDL metabolism. J Endocrinol Metab. 2014;4(3):51-55 doi: http://dx.doi.org/10.14740/jem224w
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.